FDA Investigator Kshitij A Patkar
Kshitij A Patkar has conducted inspections on 8 sites in 5 countries as of 20 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
20 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China,
India,
Czechia,
Ireland
FDA Investigators that have inspected at least one site in common with Kshitij A Patkar:
Ademola O Daramola,
Alicia M Mozzachio,
Alison N Stieg,
Ana Paulap Sandee,
Anastasia I Onuorah,
Anastasia M Shields,
Andrew J Barrowcliff,
Anthony R Bucks,
Ariel Cruz Figueroa,
Arulvathani P Arudchandran,
Atul J Agrawal,
Bo Chi, PhD,
Brian D Nicholson,
Brooke K Higgins,
Brooke K Seeman,
Bruce H Mccullough,
Carl A Huffman, III,
CDR Ileana Barreto Pettit,
Chaltu Nwakijra,
Charles I Ann,
Chih Jung Hsu, PhD,
Christopher D Leach,
Darryl T Newell,
David Perkins,
Debra I Love,
Denise M Digiulio,
Dennis Cantellops Paite,
Dennis L Doupnik,
Diane T Bargo,
Diane T O'brien,
Douglas A Campbell,
Dr. Zhihao Qiu (Peter), PhD,
Eboni S Funderburk,
Edwin Martinez,
Elizabeth L Philpy,
Emest F Bizjak,
Emilio O Escobar,
Eric M Padgett,
Erika V Butler,
Erin D Mccaffery,
Francis A Guidry,
Frank Wackes,
Georgia A Layloff,
Guerlain Ulysse,
Hongjian Ding,
Jacob G Lutz,
Jai P Singh,
James I Giefer,
James M Mason,
Janet A Rajan,
Javier E Santos,
Jawaid Hamid,
Jeffrey P Raimondi,
Jing Fang,
Joel D Hustedt,
John P Mistler,
Johnna L Bleem,
Jonathan W Chapman,
Jose M Cayuela,
Joshua M Adams,
Junho Pak,
Karen C Daugherty,
Katelyn Astaub Zamperini,
Ko U Min,
Lakshmi Narasimhan, PhD,
Lareese K Thomas,
Laura Fontan, MS,
Laurie A Haxel,
Lawrence J Stringer,
Lequita M Mayhew,
Libia M Lugo,
Luis A Dasta,
Marcus A Ray,
Maria Cecilia Tami, PhD,
Maria Gutierrez Hoffman, PhD,
Marijo B Kambere, PhD,
Mark G Peterson,
Mary E Storch,
Massoud Motamed,
Melissa J Garcia,
Melissa T Roy,
Michael Shanks, MS,
Michele Gottshall,
Michele L Glendenning,
Michele Perry Williams,
Michelle Marsh,
Milos Dokmanovic, PhD,
Mra Davism,
Nancy M Espinal,
Nicholas P Diorio,
Patrick C Klotzbuecher,
Paula J Bretz,
Phung Thien Nguyen,
Pratik S Upadhyay, DDC,
Qin Xu,
Rabin N Ghoshal,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Richard Ledwidge (nmi), PhD,
Rita K Kabaso,
Robert J Ham,
Robin P Mathew,
Ross J Grigsby,
Russell K Riley,
Samina S Khan,
Sandra A Hughes,
Sangeeta M Khurana, PhD,
Sean R Marcsisin,
Sherry G Bous,
Shirley J Berryman,
Sixto M Mercado Rios,
Sneha S Patel,
Sony Mathews,
Sonya M Edmonds,
Stephen J Mottola,
Steven D Kehoe,
Susan D Yuscius,
Susan P Bruederle,
Tamika White,
Tamil Arasu, PhD,
Thomas J Arista,
Toyin B Oladimeji,
Wayne E Seifert,
William A Warnick,
William Hallett, PhD,
William L Bargo,
Xu Michael Di, PhD,
Yun Wu, PhD,
Yvonne E Lozano,
Zhong Li, PhD
Kshitij A Patkar's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2017 | FDA 483 | Sigma-Aldrich Manufacturing LLC - Form 483, 2017-03-10 |
| June, 2019 | FDA 483 | Ajanta Pharma Limited - Form 483, 2019-06-22 |
| March, 2017 | EIR | Sigma-Aldrich Manufacturing LLC - EIR, 2017-03-10 |
| May, 2013 | FDA 483 Response | Rising Pharma Holdings, Inc. - Form 483R, 2013-05-03 |
| March, 2013 | FDA 483 | Ambiopharm, Inc. - Form 483, 2013-03-28 |
| August, 2017 | FDA 483 | Mylan Pharmaceuticals Inc. - Form 483, 2017-08-25 |
| May, 2013 | FDA 483 | Rising Pharma Holdings, Inc. - Form 483, 2013-05-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more